亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Spatiotemporal Genomic Analysis to Identify and Extract Rare Cancer Cells

標題
Separation of Rare Cells and Genomic Analysis Thereof
詳細技術說明
ApplicationIsolation and analysis of phenotype and genome of rare cell types within a tumor for research and potential diagnostics.Key BenefitsAllows the identification of a single cell or group of cells within a tumor sample using phenotypic criteria.Enables both phenotypic and genetic analysis of the same rare cells within a tumor.Market SummaryFor many years, tumors were thought to be homogeneous, made up of a single proliferative cancer cell type. Today, tumors are thought to be comprised of a variety of cell types. Cells within a tumor can vary across cellular morphology, gene expression, metabolism, motility, proliferation, and metastatic potential. This heterogeneity is believed to contribute to challenges faced by oncologists in designing effective treatment strategies because not all cells will respond the same to a single therapy. Tools are needed to study rare cell types within a tumor and connect genomic information to a particular subset of rare tumor cells.Technical SummaryEmory University researchers have developed a method for precisely selecting a single cell or group of cells from a tumor sample. This method allows the collection of both morphological and phenotypic information about those tumor cells as well as gather specific genetic information of those same cells. The cells are selected using cellular imaging and the target cells are exposed to UV light to precisely photoconvert the photoconvertible fluorophore in the cells. This is followed by cell sorting to isolate those marked cells. Genomic analysis of choice may then be run on the sorted cells of interest, and cells are viable post-sorting for molecular analysis. This technique may contribute to better understanding of rare subpopulations in tumors as well as development of cancer therapeutics. Developmental StageCurrently being used to identify new diagnostic panels and screen for oncology drugs.View our featured innovation.Publications: Konen, J. et al. (2017) Nature Communications, 8.
*Abstract
None
*Principal Investigation

Name: Adam Marcus, Associate Professor

Department: SOM: HMO: Med Onc


Name: Jessica Konen, Graduate Student

Department: GRS:_GDBBS_Cancer_Biology

申請日期
May 5, 2017
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備